Quick answer : Finishing an initial ketamine infusion series is usually not the end of treatment. Some patients maintain improvement for extended periods, while others benefit from individualized maintenance or booster treatments. There is no single maintenance schedule that works for everyone. The period after an initial series is also an opportunity to strengthen sleep, therapy, exercise, relationships, metabolic health, and other factors that may help make improvement more durable.
An initial ketamine series is designed to determine whether someone responds to treatment and to build that response over multiple treatments. Unlike a medication taken every day, IV ketamine for depression is often administered as a series of treatments over a relatively short period.
The exact protocol can vary between practices and patients. What matters clinically is whether symptoms and function are changing enough to justify continuing treatment.
By the end of the initial series, the question becomes less about whether ketamine can produce a response and more about how that response can be maintained.
No. There is no universal schedule for maintenance IV ketamine, and not every patient needs ongoing treatment at the same frequency.
Ketamine’s antidepressant effects can be rapid but may also diminish over time. Systematic reviews of maintenance treatment suggest that repeated ketamine can help sustain antidepressant effects in some people with treatment-resistant depression, while also emphasizing that long-term protocols remain less standardized than acute treatment.
Some patients may return periodically for booster infusions, while others may go considerably longer between treatments. The goal should be individualized treatment based on clinical response rather than automatically placing everyone on the same indefinite schedule.
One useful strategy is to pay attention to early signs of symptom recurrence rather than waiting until someone is back at their pretreatment baseline.
Those changes may include increasing rumination, declining motivation, worsening sleep, social withdrawal, loss of interest, increasing anxiety, or difficulty completing normal daily activities. Standardized measures such as the PHQ-9 can also help track symptoms over time.
The goal is to look at the overall trajectory rather than making a decision based on one unusually good or bad day.
This is one of the most important parts of the treatment plan. Ketamine should not have to carry the entire burden of maintaining someone’s mental health.
Depending on the individual, the period between treatments may include psychotherapy, regular exercise, improving sleep, addressing metabolic health, reducing problematic alcohol or cannabis use, strengthening relationships, managing stress, and returning to meaningful activities.
There is also growing interest in combining ketamine with psychotherapy. Systematic reviews suggest that this approach is promising, but studies use different therapies, ketamine protocols, and timing, so the evidence is not yet strong enough to establish one optimal method.
A depression questionnaire provides useful information, but it does not tell the entire story. Someone’s PHQ-9 may improve while they are still socially isolated and unable to return to normal activities. Conversely, functional improvement may begin before a dramatic change appears on a questionnaire.
We want to know whether someone is getting out of bed more easily, exercising again, reconnecting with family, returning to work, enjoying activities, making plans, and spending less time trapped in repetitive negative thinking.
Those changes help us understand whether treatment is producing a meaningful improvement in life rather than simply changing a number.
No. Depression is frequently recurrent, and needing additional treatment does not necessarily mean the original treatment failed.
The more important question is whether the treatment continues to produce meaningful benefit and whether that benefit justifies the burden, cost, and potential risks of continued treatment.
Over time, we would generally prefer to identify the least intensive treatment schedule that maintains meaningful improvement rather than administering ketamine more frequently than necessary.
Completing an initial ketamine series is better viewed as the transition from acute treatment to a longer-term recovery strategy rather than the finish line.
Some patients may benefit from maintenance ketamine, while others may maintain improvement through other components of their treatment plan. The goal is not simply to continue infusions indefinitely. It is to help someone build the most durable improvement possible with the lowest necessary treatment burden.
There is no single maintenance schedule that applies to everyone. Frequency should be individualized according to symptom recurrence, functional changes, duration of response, tolerability, and clinical judgment.
No. Some patients benefit from periodic maintenance treatments, while others may maintain improvement for longer periods without additional infusions. Current research has not established one optimal long-term protocol.
Depending on your individual needs, psychotherapy, exercise, restorative sleep, nutrition, stress regulation, relationships, and addressing relevant medical or metabolic factors can all be important parts of maintaining recovery.
